Covestor
BIO icon

Covestor’s Bio-Rad Laboratories Class A BIO Stock Holding History

Covestor’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$82K Sell
218
-69
-24% -$24.1K 0.05% 453
2026
Q2 		$84K Buy
287
+269
+1,494% +$76.3K 0.05% 460
2026
Q1 		$5K Sell
18
-52
-74% -$15K ﹤0.01% 1779
2025
Q4 		$21K Buy
70
+38
+119% +$11.9K 0.01% 1261
2025
Q3 		$9K Sell
32
-58
-64% -$15.8K 0.01% 1636
2025
Q2 		$22K Buy
90
+48
+114% +$11.3K 0.01% 1215
2025
Q1 		$10K Sell
42
-14
-25% -$4.21K 0.01% 1474
2024
Q4 		$19K Sell
56
-75
-57% -$25.5K 0.01% 1206
2024
Q3 		$44K Buy
131
+22
+20% +$6.99K 0.03% 922
2024
Q2 		$30K Buy
109
+45
+70% +$13.1K 0.02% 1048
2024
Q1 		$22K Buy
64
+48
+300% +$15.8K 0.01% 1180
2023
Q4 		$5K Hold
16
– – ﹤0.01% 1762
2023
Q3 		$6K Sell
16
-1
-6% -$386 ﹤0.01% 1662
2023
Q2 		$7K Sell
17
-155
-90% -$63.1K 0.01% 1624
2023
Q1 		$83K Sell
172
-33
-16% -$15.4K 0.07% 479
2022
Q4 		$87K Buy
205
+1
+0.5% +$404 0.07% 464
2022
Q3 		$85K Buy
204
+9
+5% +$4.49K 0.07% 435
2022
Q2 		$97K Buy
195
+26
+15% +$13.5K 0.08% 435
2022
Q1 		$95K Buy
169
+92
+119% +$55.5K 0.06% 534
2021
Q4 		$59K Buy
+77
New +$57.6K 0.08% 435

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Ariel Investments
Ariel Investments Chicago, Illinois $9.6B AUM 22.21% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $25.4B AUM 35.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $148B AUM 31.56% 1-Year Est. Return

Covestor's BIO Position: Q3 2026 in Review

Covestor reduced its Bio-Rad Laboratories Class A (BIO) stake by 24% in Q3 2026, selling an estimated $24.1K and leaving 218 shares worth $82K. The position accounts for 0.05% of the portfolio, ranked #453.

Covestor first reported a position in BIO in Q4 2021 and has held it in 20 quarters since. The position peaked at $97K in Q2 2022. 327 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

  • Covestor held 218 shares of Bio-Rad Laboratories Class A worth $82K as of Q3 2026.
  • Covestor sold 69 Bio-Rad Laboratories Class A shares in Q3 2026, an estimated $24.1K.
  • Bio-Rad Laboratories Class A made up 0.05% of Covestor's portfolio in Q3 2026, its #453 holding.
  • Covestor first reported a position in Bio-Rad Laboratories Class A in Q4 2021 and has held it in 20 quarters since.
  • Covestor's Bio-Rad Laboratories Class A position peaked at $97K in Q2 2022.
  • 327 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.